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A clinical reappraisal study was carried out in conjunction with the Army Study
to Assess Risk and Resilience in Servicemembers (Army STARRS) All-Army
Study (AAS) to evaluate concordance of the Diagnostic and Statistical Manual
of Mental Disorders, Fourth Edition (DSM-IV) diagnoses based on the
Composite International Diagnostic Interview Screening Scales (CIDI-SC) and
post-traumatic stress disorder (PTSD) checklist (PCL) with diagnoses based
on independent clinical reappraisal interviews (Structured Clinical Interview
for DSM-IV [SCID]). Diagnoses included: lifetime mania/hypomania, panic
disorder, and intermittent explosive disorder; six-month adult attention-
deﬁcit/hyperactivity disorder; and 30-day major depressive episode, generalized
anxiety disorder, PTSD, and substance (alcohol or drug) use disorder (abuse or
dependence). The sample (n= 460) was weighted for over-sampling CIDI-SC/
PCL screened positives. Diagnostic thresholds were set to equalize false positives
and false negatives. Good individual-level concordance was found between
CIDI-SC/PCL and SCID diagnoses at these thresholds (area under curve303
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accepted 15 July 2013304[AUC] = 0.69–0.79). AUC was considerably higher for continuous than dichot-
omous screening scale scores (AUC= 0.80–0.90), arguing for substantive analy-
ses using not only dichotomous case designations but also continuous measures
of predicted probabilities of clinical diagnoses. Copyright © 2013 John Wiley &
Sons, Ltd.Introduction
As described in more detail earlier in this issue (Kessler
et al., 2013b) and elsewhere (Ursano et al., submitted for
publication), the Army Study to Assess Risk and Resilience
in Servicemembers (Army STARRS; http://www.armystarrs.
org) is a multi-component epidemiological and neurobio-
logical study of risk and resilience factors for suicidality
and its psychopathological correlates in the US Army. The
literature on risk and resilience factors for suicidality makes
it clear that mental disorders are powerful risk factors (Nock
et al., 2008; Nock et al., 2013). As a result, a wide range of
mental disorders were assessed in the Army STARRS
surveys. However, due to the size and logistical complexities
of these surveys, which are described earlier in this issue
(Heeringa et al., 2013), it was impossible to administer an
in-depth psychiatric diagnostic interview to participants.
Instead, mental disorders were assessed with short self-
administered screening scales.
A number of screening scales exist to assess such
disorders as attention-deﬁcit hyperactivity disorder
(ADHD; Kessler et al., 2005a), bipolar disorder (BPD;
Hirschfeld et al., 2000), generalized anxiety disorder
(GAD; Spitzer et al., 2006), major depressive episode
(MDE; Kroenke et al., 2001), and post-traumatic stress
disorder (PTSD; Breslau et al., 1999). Although in some
cases these scales were developed originally to assess
symptom severity among patients in treatment, they
subsequently have been adapted for use either as web-
based tools for self-diagnosis (Donker et al., 2009;
Farvolden et al., 2003) or as brief evaluations of mental
disorders in primary care settings or community surveys
(Broadhead et al., 1995; Gaynes et al., 2010; Hunter
et al., 2005; Kessler et al., 2013a). Clinical reappraisal
studies comparing scores on these screening scales with
independent clinical diagnoses show that many of these
screening scales have good concordance with clinical
diagnoses (Kessler and Pennell, in press).
The screening scales that form the core diagnostic
assessment in Army STARRS are the World Health Orga-
nization (WHO) Composite International Diagnostic
Interview Screening Scales (CIDI-SC) (Kessler et al.,
2013a). These were selected largely because they are aInt. J. Metcoordinated set of short scales that cover a wide range of dis-
orders and have good psychometric properties. However,
another appeal of the CIDI-SC is that they are embedded
in the WHO Composite International Diagnostic Interview
(CIDI) (Kessler and Üstün, 2004), the research diagnostic
interview used in most large-scale epidemiological surveys
of psychiatric disorders throughout the world (Haro et al.,
2006). Use of the CIDI-SC in Army STARRS thereby creates
a crosswalk to an in-depth diagnostic interview that might
be used inmore focused follow-up studies of Army STARRS
high-risk subsamples. The exception is that we used the
PTSD checklist (PCL) (Weathers et al., 1993) to assess PTSD
based on the widespread use of this screening scale in previ-
ous military studies of PTSD (Barnes et al., 2013; Brown
et al., 2012; Jones et al., 2013) coupled with strong evidence
for the validity of the PCL in both military and civilian
samples (Wilkins et al., 2011).
Although good concordance of the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV; American Psychiatric Association, 1994) diag-
noses based on the CIDI-SC (Kessler et al., 2005a; Kessler
et al., 2007; Kessler et al., 2006a; Kessler et al., 2013a) and
PCL (Wilkins et al., 2011) with diagnoses based on inde-
pendent clinical reappraisal interviews has been reported
in a number of studies, this does not guarantee that these
screening scales will perform equally well among soldiers
in the Army STARRS surveys. As a result, a new clinical
reappraisal study (CRS) was carried out in conjunction with
the Army STARRS All-Army Study (AAS) (Ursano et al.,
submitted for publication) to examine the psychometric
characteristics of the CIDI-SC and PCL in the context of the
ﬁeld conditions encountered in the Army STARRS surveys.
Results of this CRS are presented in the current report.Methods
The samples
The All-Army Study (AAS)
As described in more detail previously in this issue
(Kessler et al., 2013b), the AAS is a cross-sectional survey
of active duty Army personnel exclusive of soldiers in basichods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.1002/mpr
Copyright © 2013 John Wiley & Sons, Ltd.
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total of nearly 50,000 soldiers during calendar years
2011–2012. Each quarterly AAS replicate consisted of a
stratiﬁed (by Army Command-location and unit size)
probability sample of Army units, excluding units of fewer
than 30 soldiers (less than 2% of all Army personnel). All
targeted personnel in these units were ordered to attend an
informed consent presentation explaining study purposes,
conﬁdentiality procedures, and the voluntary nature of
participation before requesting written informed consent
for a group self-administered questionnaire (SAQ). Re-
spondents were additionally asked for consent to link their
Army and Department of Defense administrative records
to their SAQ responses and to participate in future longi-
tudinal follow-up data collections. Identifying information
(name, birthday, Social Security number for record link-
age; telephone number, email, secondary contact informa-
tion for longitudinal follow-up) was collected from
consenting respondents and kept in a separate secure ﬁle.
These recruitment, consent, and data protection proce-
dures were approved by the Human Subjects Committees
of the Uniformed Services University of the Health Sci-
ences for the Henry M. Jackson Foundation (the primary
grantee), the Institute for Social Research at the University
of Michigan (the organization implementing Army
STARRS surveys), and all other collaborating
organizations.
The CRS was carried out between March 2012 and
November 2012. All quarterly AAS replicates over that
time period were based on representative samples of
soldiers stationed both in the continental United States
and elsewhere in the world other than a combat theater,
while the Q2–3 2012 replicates also included probability
samples of soldiers stationed in Afghanistan who were
surveyed in group-administered sessions while they were
passing through Kuwait either leaving for or returning from
their mid-tour leave. However, because of logistical issues
requiring that the CRS interviews be administered within
two weeks of the AAS survey, the CRS was implemented
exclusively in the continental United States among Regular
(active component) Army AAS respondents providing
consent for administrative data linkage and completing
the SAQ. Activated Army Reserve and National Guard
respondents were excluded from the CRS due to small
numbers.
Although, as noted earlier, all unit members in these
replicates were ordered to report to the informed consent
session, 19.4% of those in the replicates used for the CRS
were absent due to conﬂicting duty assignments. The vast
majority of those attending (99.6%) consented to the
survey and 98.8% of consenters completed the survey. InInt. J. Methods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.100
Copyright © 2013 John Wiley & Sons, Ltd.addition, 71.4% of completers provided successful record
linkage. Most incomplete surveys were due to logistical
complications (e.g. units either arriving late to survey
sessions or having to leave early), although some respon-
dents needed more than the allotted 90 minutes to
complete the survey. The survey completion-successful-
linkage cooperation rate was 63.9% and the completion-
successful-linkage response rate was 51.5% based on the
American Association of Public Opinion Research COOP1
and RR1 calculation methods (American Association for
Public Opinion Research, 2009).The clinical reappraisal study (CRS) sample
In order to evaluate the concordance of diagnoses based
on the CIDI-SC and PCL in the AAS with independent
clinical diagnoses, a sample of AAS respondents was
selected to participate in clinical follow-up interviews
within two weeks of completing the AAS in selected AAS
sessions. As soon as the AAS survey was completed in
these sessions, each AAS respondent was classiﬁed as
threshold, subthreshold or no on each of the eight screening
scales considered here. A probability subsample of AAS
respondents from the session was then invited to partici-
pate in a conﬁdential clinical reappraisal interview with
the goal of obtaining a total (i.e. over the entire nine-
month interview recruitment period) of 30 CRS interviews
with respondents selected at random from those classiﬁed
as threshold cases on each diagnosis, 10 from among those
classiﬁed as subthreshold on each diagnosis, and 40
respondents selected at random from those classiﬁed as
meeting neither threshold nor subthreshold criteria for
any diagnosis. CRS respondents with each diagnosis were
selected with replacement (i.e. the same respondent could
be selected for more than one diagnosis). The initial
sampling fractions varied across disorders due to differ-
ences in prevalence among the disorders. These sampling
fractions were then modiﬁed over sessions in order to
achieve a roughly equal distribution of cases within each
diagnosis across sessions while meeting the sample quotas.
The 460 clinical interviews completed by the end of the
CRS is more than the 360 needed (i.e. 30 interviews with
threshold CIDI-SC/PCL cases for each of eight disorders plus
10 interviews with CIDI-SC/PCL subthreshold cases for each
of these disorders plus 40 respondents screening negative on
all eight CIDI-SC/PCL scales) because it was necessary to
recruit additional respondents in the later replicates to ﬁll
the sample quotas for the least common disorders.
Invitations to participate in the CRS were made
through unit points of contact who scheduled two-hour
time blocks during which respondents were relieved of2/mpr
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Army STARRS ofﬁce on the installation. Once at the study
ofﬁce, an Army STARRS data collection specialist explained
the content and purposes of the CRS and obtained written
informed consent to participate. Consenting respondents
were then assigned to a private room where they were
administered the CRS interview telephonically by one of
the CRS clinical interviewers, all of whom were located at
the Uniformed Services University of the Health Sciences
(USUHS) in Bethesda, Maryland. The CRS clinical supervi-
sor (CLD), also located at USUHS, coordinated with Army
STARRS data collection specialists at the local AAS installa-
tions to schedule these remote CRS telephone interviewers.An overview of screening scale content
Screening scales were included in the AAS for eight
DSM-IV disorders that have been found in previous general
population studies to be signiﬁcant predictors of suicidality
(Nock et al., 2008; Nock et al., 2013; Nock et al., 2009).
These include two mood disorders (MDE, mania/hypoma-
nia [MHM]), three anxiety disorders (panic disorder with
or without agoraphobia, GAD, PTSD), and three externaliz-
ing disorders (adult ADHD, intermittent explosive disorder,
substance use disorder [SUD]).
Symptom questions in most CIDI-SC ask respondents
about the frequency of particular symptoms over the
30 days before interview using the response options all or
almost all of the time, most of the time, some of the time, a
little of the time, and none of the time. Each CIDI-SC has
an embedded skip logic whereby all respondents are
administered one or more entry questions and then either
skipped if they fail to endorse these questions or continue
to a series of follow-up questions if they endorse the entry
question(s). This approach was designed to reduce overall
scale administration time and respondent burden while
minimizing the number of true positives incorrectly
skipped out by the entry questions. Respondents who fail
to endorse any of the entry questions are asked a total of
46 questions across all eight scales combined, while
respondents who endorse every single question are asked
an additional 82 questions.
The CIDI-SC MDE scale begins with four entry ques-
tions that ask about being sad, depressed, or discouraged,
having little or no interest or pleasure in things, and feeling
down on yourself, no good, or worthless (Kessler et al.,
2013a). Respondents who report that at least one of these
symptoms occurred at least some of the time in the past 30
days are administered 10 additional questions to assess the
inclusion criteria of MDE. The some of the time threshold,
while low for a DSM-IV diagnosis of MDE (which requiresInt. J. Met
306depressive symptoms to last most of the day nearly every
day for two weeks or longer), was chosen because we
wanted to collect information not only on threshold cases
but also on subthreshold manifestions of MDE. A similar
attempt to collect information about subthreshold symp-
toms was made in selecting stem question skip rules for
each of the other screening scales.
The CIDI-SC MHM scale focuses on subthreshold
hypomania as well as mania and hypomania based on
evidence that subthreshold hypomania can be highly
impairing (Merikangas et al., 2007). In addition, the ques-
tions focus on lifetime rather than 30-day prevalence due
to the fact that recent BPD can manifest as either MHM
or as MDE. As described in more detail elsewhere (Kessler
et al., 2006a; Kessler et al., 2013a), the single MHM entry
question begins with a vignette describing a hypomanic
episode and then asks respondents if they ever had an
episode of this sort at any time in their life. A positive
response is followed by four questions about the frequency
of core MHM symptoms during a typical intense episode of
this sort. These symptoms include being much higher,
happier, or optimistic than usual; much more irritable than
usual; so hyper or wound up that you felt out of control;
having thoughts race through your mind so fast you could
hardly keep track of them. Respondents who report that at
least one of these symptoms occurrs at least some of the
time during a typical intense episode are then administered
six additional questions about the inclusion criteria of
MHM and are then asked about episode recency to assess
30-day prevalence of MHM. Lifetime rather than 30-day
MHM is evaluated here due to the rarity of 30-day
MHM in the AAS sample.
The CIDI-SC panic disorder (PD) scale includes two
entry questions about lifetime atacks of panic, anxiety, or
strong fear that came on very suddenly and made you feel
very frightened or uneasy; and attacks of heart pounding or
chest pain that came on very suddenly and made you feel very
frightened or uneasy (Kessler et al., 2013a). A positive
response to either entry question is followed by one
additional question on how often these attacks are trig-
gered (i.e. occur in situations where the respondent has a
strong fear – like a fear of snakes or heights – or where
the respondent is in real danger – like a car accident)
versus untriggered (i.e. occur without provocation “out of
the blue”). Respondents who report ever having untriggered
attacks are then administered 13 additional questions to
assess the remaining DSM-IV inclusion criteria of PD.
Lifetime rather than 30-day PD is evaluated here due to
the rarity of 30-day PD in the AAS sample.
The CIDI-SC GAD scale includes ﬁve entry questions
about 30-day frequency of being anxious or nervous;hods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.1002/mpr
Copyright © 2013 John Wiley & Sons, Ltd.
Kessler et al. Clinical reappraisal of the CIDI-SC in Army STARRSworried about a number of different things; more anxious or
worried than other people in your same situation; worried
about things most other people don’t worry about; and
having trouble controlling your worry or anxiety (Kessler
et al., 2013a). Respondents who report any of these
symptoms at least some of the time are administered an
additional nine questions to assess the remaining
DSM-IV inclusion criteria of GAD along with a ﬁnal
question to assess persistence of symptoms. As a mini-
mum duration of six months is required to meet DSM-
IV criteria of GAD, the CIDI-SC assesses duration of
symptoms, although the concordance data reported
here are for symptoms in the 30-days before interview.
As noted earlier, PTSD is assessed in the AAS with the
PCL. The PCL Civilian version (Weathers et al., 1993) was
used in Army STARRS because we covered traumatic
experiences both in and out of the line of duty. This is a
17-question scale that assesses the 17 DSM-IV Criterion
B–D symptoms of PTSD. Although there are no entry
questions in the PCL, AAS respondents are ﬁrst asked
15 questions about traumatic experiences (TEs) that might
have happened to them during deployments and 15 addi-
tional questions about TEs that might have happened to
them at any other time in life. Only respondents who report
at least one of these 30 TEs are administered the PCL. The
PCL questions ask how much respondents were bothered in
the past 30 days by symptoms associated with any of the
TEs they ever experienced. Response categories are
extremely, quite a bit, moderately, a little bit, and not at all.
The CIDI-SC adult ADHD scale includes four entry
questions found in previous research to provide an opti-
mal short inclusion screen for ADHD in the adult general
population (Kessler et al., 2010a). Respondents who report
at least two of these symptoms at least some of the time in
the past six months then receive an additional eight ques-
tions shown in a number of previous studies to detect
adult ADHD with good accuracy (Kessler et al., 2007;
Kessler et al., 2010a; Kessler et al., 2009).
The CIDI-SC intermittent explosive disorder (IED)
scale includes one entry question about lifetime attacks
of anger when the respondent all of a sudden… lost control
and either broke or smashed something worth more than a
few dollars, hit or tried to hurt someone, or threatened some-
one (Kessler et al., 2006b). A positive response is followed
by six additional questions that assess the remaining
DSM-IV inclusion criteria of IED. As the assessment of
IED followed the same logic as the assessment of PD, life-
time rather than 30-day IED is evaluated here in parallel
with the evaluation of PD.
The CIDI-SC assessment of SUD, ﬁnally, begins
with 12 entry questions about quantity-frequency ofInt. J. Methods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.100
Copyright © 2013 John Wiley & Sons, Ltd.alcohol use, illicit drug use, and prescription drug
misuse, where the latter is deﬁned as use either without
a doctor’s prescription, more than prescribed, or to get
high, buzzed, or numbed out. Prescription drug misuse
is included in the assessment based on evidence that
it is considerably more common than illicit drug use
in the Army (Bray et al., 2010). Respondents who
report any of these types of substance use are then
administered the four CIDI-SC questions about DSM-IV
substance abuse in the 30 days before interview and eight
additional questions to screen for substance dependence
in the 30 days before interview including ﬁve from the
Severity of Dependence Scale (Gossop et al., 1995) and
three additional CIDI-SC questions. SUDs (i.e. either
abuse or dependence) are assessed only once for alcohol
and/or drugs combined.Scoring the screening scales
Each screening scale was initially scored continuously by
summing values across all items in the scale, assigning
respondents who were skipped out after screening ques-
tions the lowest possible scores on the remaining items.
Receiver operating characteristic (ROC) curve analysis
(Margolis et al., 2002) was then used to estimate area
under the ROC curve (AUC) for the entire continuous
scale and to dichotomize the scale at a point that opti-
mized aggregate concordance between the prevalence
estimate based on the Structured Clinical Interview for
DSM-IV (SCID) and the prevalence estimate based on
the CIDI-SC at the designated threshold. This threshold
also makes the number of false positives equal the number
of false negatives. It is noteworthy, though, that other
criteria exist to select diagnostic thresholds and that
decisions about which threshold to choose can vary
depending on the criterion used. For example, if we had
wanted to use the screening scales in a primary care setting
to select patients for more in-depth evaluation, we might
have lowered the threshold to the point where the vast
majority of SCID cases were detected. Or if we were using
the screening scales to select patients for a clinical
intervention, we might have raised the threshold to the
point where the vast majority of screened positives
consisted of SCID cases. If the relative importance of min-
imizing false positives and minimizing false negatives can
be speciﬁed based on the considerations of such compet-
ing criteria, it is possible to minimize this weighted sum
of errors in a formal way (Kraemer, 1992). Based on these
considerations, a number of alternative thresholds are
examined later.2/mpr
307
Clinical reappraisal of the CIDI-SC in Army STARRS Kessler et al.The clinical reappraisal interview
The clinical reappraisal interview was a modiﬁed Research
Version, Non-Patient Edition of the Structured Clinical
Interview for DSM-IV (SCID-I) (First et al., 2002) focused
on the eight syndromes under study with the variations in
recall periods noted earlier to match the recall periods
used in the screening scales. As noted earlier, these inter-
views were administered by telephone. Telephone admin-
istration is now widely accepted in clinical reappraisal
studies based on evidence of comparable validity to in-
person administration (Kendler et al., 1992; Rohde et al.,
1997; Sobin et al., 1993). A great advantage of telephone
administration is that a centralized and closely supervised
clinical interview staff can carry out the interviews without
the geographic restrictions required for face-to-face clini-
cal assessment. A disadvantage is that people without
telephones cannot be included in the assessment. As noted
later, though, this difﬁculty was resolved in the Army
STARRS CRS by having pre-designated respondents
report to the central Army STARRS research ofﬁce on
their installations, where they were placed in a private
room and interviewed remotely by telephone.
A major impediment to making accurate evaluations of
concordance between screening scales and clinical diagno-
ses is the fact that respondents are inconsistent in their
reports over time. Indeed, our own previous experience
and that of other researchers shows consistently that
respondents in community surveys tend to report less
and less as they are interviewed more and more due to
respondent fatigue (Bromet et al., 1986). Part of this
pattern is a tendency for respondents to endorse a smaller
number of diagnostic stem questions in follow-up inter-
views than in initial interviews (Kessler et al., 1998),
leading to the biased perception that initial fully-structured
assessments overestimate prevalence compared to clinical
reappraisal interviews. Consistent with the approach used
in a number of other clinical reappraisal studies (Haro
et al., 2006; Kessler et al., 2005b; Kessler et al., 1998), we
modiﬁed the conventional blinded clinical re-interview
design in three important ways to address this problem.
First, we unblinded the clinical interviewers to whether
respondents endorsed diagnostic stem questions in the
CIDI-SC. Importantly, though, we did not unblind clinical
interviewers to whether the respondents who endorsed
CIDI-SC diagnostic stem questions went on to meet full
diagnostic criteria.
Second, we rephrased entry questions in the clinical
reappraisal interviews to acknowledge prior endorsement
of diagnostic stem questions in the CIDI-SC/PCL in order
to minimize the problem of false negative diagnostic stemInt. J. Met
308responses in the SCID. For example, rather than repeating
a question about presence-absence of 30-day depressed
mood in the SCID to respondents who reported 30-day
depressed mood in the CIDI-SC, SCID began the assess-
ment of major depression with a declarative sentence:
“In your earlier survey you reported feeling sad or
depressed most of the time over the past 30 days. The next
questions ask more about those feelings.”
Third, in order to guarantee that this partial unblinding
did not bias clinical interviewers in the direction of rating
all stem-positive respondents as cases, we enriched the
clinical reappraisal sample to include a higher proportion
of respondents than in the sample who endorsed
CIDI-SC/PCL diagnostic stem questions but did not meet
full CIDI-SC/PCL diagnostic criteria. This third feature of
the design actually makes the interviewer task more
difﬁcult than it would be in a standard CRS in which
there is an over-sample of respondents classiﬁed as
meeting full diagnostic criteria but not of respondents
meeting partial criteria.Clinical interviewer training and quality control
The SCID were administered by 14 trained clinical inter-
viewers. These included four doctoral-level psychologists,
seven MA-level psychologists, and three MSW-level clini-
cal social workers. Half of the interviewers had a decade
or more of clinical experience (10–21 years), while the
other half had 3–9 years of clinical experience (two with
three years of experience and one each with ﬁve, six, seven,
eight, and nine years of experience). The 32-hour SCID
interviewer training program began with a 16-hour
centralized group training session taking place over a full
weekend that was taught by one of the developers of the
SCID (MBF) with the assistance of an experienced SCID
supervisor (CLD). Training then continued with biweekly
individual and group training sessions with homework
assignments totaling 32 hours. The training was carried
out at USUHS using a modiﬁcation of the standard SCID
training protocol tailored to the diagnoses assessed by the
screening scales. In addition to completing this training,
each clinical interviewer was required to pass a proﬁciency
test before they began production interviewing based on
trainer and supervisor ratings of three practice interviews
using a modiﬁed version of the SCID Interviewing Skills
Evaluation Form created speciﬁcally for this study.
All SCID interviews were audio-recorded with permis-
sion of respondents and responses recorded on a hard
copy interview. The supervisor reviewed the tape record-
ings of the ﬁrst ﬁve interviews carried out by each inter-
viewer and a minimum of 10% of all subsequenthods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.1002/mpr
Copyright © 2013 John Wiley & Sons, Ltd.
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also reviewed all hard copy interviews completed by all
interviewers and reviewed tape recordings of all interviews
in which concerns were raised by the hard copy reviews.
The symptom-level hard copy clinical ratings were
double-entered into a computerized data ﬁle after supervi-
sor review and approval. Each interviewer had a weekly
one-on-one feedback meeting with the supervisor and
participated in a biweekly group calibration meeting with
the supervisor and trainer to prevent rater drift. Diagnoses
were made without diagnostic hierarchy rules but with
organic exclusions.
Analysis methods
Weighting
The CRS sample was weighted to adjust for over-sampling
respondents screened as threshold or subthreshold using a
weighting method that adjusted for the fact that sampling
was made with replacement. This is important because a
number of the statistics used to describe scale characteris-
tics are biased when differential selection of screened
positives and negatives is not taken into account.
Analysis of screening scale operating characteristics
As noted earlier in the description of screening scale
scoring, a summary continuous screening scale score was
created for each diagnosis by summing scores across the
screening scale items. ROC curve analysis (Margolis
et al., 2002) was then used to estimate AUC for the entire
scale. Each continuous screening scale was then dichoto-
mized at a threshold that equalized the (weighted) number
of false positives and false negatives, thereby maximizing
concordance between prevalence estimates based on the
SCID and the screening scales. The McNemar x2 test was
used to evaluate the signiﬁcance of differences between
screening scale and SCID prevalence estimates at this
threshold. A range of other thresholds was then selected
so that SCID prevalence estimates increased monotoni-
cally across screening scale strata but did not differ signif-
icantly within strata using the logic of stratum-speciﬁc
likelihood ratio analysis (Pepe, 2003).
Screening scale operating characteristics were then
evaluated for each of these thresholds. Individual-level
concordance was evaluated using AUC and Cohen’s κ
(Cohen, 1960). Although κ is the traditional measure used
in psychiatric research, κ is not emphasized here because it
varies across populations that differ in prevalence even
when sensitivity (SN; the percent of true cases correctly
classiﬁed) and speciﬁcity (SP; the percent of true non-Int. J. Methods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.100
Copyright © 2013 John Wiley & Sons, Ltd.cases correctly classiﬁed) are constant (Cook, 1998).
AUC, in comparison, is a function of SN and SP, which
are considered the fundamental parameters of agreement
(Kraemer, 1992). AUC equals (SN+ SP)/2 when the
screen is dichotomous. AUC scores between 0.5 and
1.0 are often interpreted in parallel with κ as slight
(AUC= 0.50–0.59; κ = 0.0–0.19), fair (AUC= 0.6–0.69;
κ= 0.2–0.39), moderate (AUC= 0.7–0.79; κ= 0.4–0.59),
substantial (AUC= 0.8–0.89; κ= 0.6–0.79), and almost
perfect (AUC= 0.9+; κ= 0.8+) (Landis and Koch, 1977).
We also report total classiﬁcation accuracy (TCA), the
proportion of all respondents whose CIDI-SC and SCID
classiﬁcations are consistent.
In addition, we report disaggregated measures of
operating characteristics, including SN and SP, positive
predictive value (PPV; the proportion of screened posi-
tives conﬁrmed by the SCID), negative predictive value
(NPV; the proportion of screened negatives conﬁrmed
as non-cases by the SCID), likelihood ratio positive
(LR+; [SN/(100 SP)]), and likelihood ratio negative
(LR; [(100 SN)/SP)]). LR + and LR assess relative
proportions of screened positives versus screened nega-
tives conﬁrmed as cases (LR+) or non-cases (LR).
LR + values greater than or equal to ﬁve and LR
values less than or equal to 0.2 are generally considered
useful, while LR + values greater than or equal to 10
and LR values less than or equal to 0.1 are considered
sufﬁcient to rule in/out diagnoses (Haynes et al., 2006).
Signiﬁcance tests were based on Taylor series design-
based standard errors to adjust for data weighting
(Wolter, 1985).Multiple imputation of predicted probabilities
of DSM-IV/SCID diagnoses
As noted earlier in the subsection on scoring the screening
scales, each screening scale was originally scored continu-
ously and then dichotomized. However, it is not necessary
to dichotomize screening scales to make them useful. This
is true even in clinical applications, where simple dichoto-
mous scoring rules can be reﬁned by using polychotomous
rules that collapse screening scale scores into strata based
on analysis of data in a CRS such that the observed preva-
lence of the clinical outcome differs signiﬁcantly across
strata but not within strata (Guyatt and Rennie, 2001).
Designations of patients into multiple risk strata can be
useful for clinical purposes when no sharp distinction
between cases and non-cases exists in the screening scale
(e.g. borderline hypertension).
An extension of this approach can be used in epidemi-
ological surveys to classify respondents into multiple risk2/mpr
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predicted probabilities of clinical diagnoses to respon-
dents in each stratum based on the results of a clinical
reappraisal survey. It is also possible to ignore the con-
struction of strata in this approach when a monotonic
association exists throughout the scale range between
a screening scale and probability of a diagnosis, in
which case regression analysis can be used to generate
predicted probabilities of clinical diagnoses for each
respondent in a large sample based on regression coef-
ﬁcients estimated in a smaller clinical reappraisal sub-
sample. These predicted probabilities can then be used
either as continuous variables or as the basis for making
dichotomous distinctions using any of several different
methods discussed elsewhere (Kessler et al., 2010b;
Kessler and Pennell, in press).
The creation of continuous scores of this sort is only
useful, though, when signiﬁcant monotonic associations
exist between screening scale scores and probabilities of
having the clinical diagnosis. We demonstrate later that
such associations exist between screening scale scores
and diagnoses based on the SCID in the Army STARRS
data by comparing AUC for the continuous versions of
the screening scales with AUC based on various dichoto-
mous versions of the scales. Given that these monotonic
associations exist, we used the method of multiple imputa-
tion (MI) (Rubin, 1987) to assign predicted probabilities
of SCID diagnoses based on screening scale scores to all
respondents in the Army STARRS surveys. MI is a two-
phase method designed to impute missing values of partic-
ular variables to respondents who have information on
variables strongly related to the variable(s) with missing
values in such a way as to maximize the use of all available
data in examining multivariate associations.
The ﬁrst phase of MI develops prediction equations
based on any of several different complex search methods
(Schafer, 2003; White et al., 2011) to estimate multivariate
associations of predictors with the variables to be imputed
in the subset of respondents with complete data and to use
those equations to generate predicted values (imputations)
for the missing variables in the remainder of the sample.
In order to address the fact that imputed values are less
precise than observed values, this ﬁrst phase uses
pseudo-replication (i.e. estimation of a new set of coefﬁ-
cients based on the same model from pseudo-samples
selected with replacement from the actual sample of
people with complete data) to generate multiple impu-
tations for each missing value. The second phase of MI,
in which the multiple imputations are used in substan-
tive analysis, then uses each set of imputed values to
carry out the substantive analysis separately and thenInt. J. Met
310combines the coefﬁcient values across these replications
to adjust standard errors of estimates for the fact that
some of the data used in the analyses were imputed
rather than observed.
Importantly, the ﬁrst phase of MI allows the inclusion
not only of a screening scale (in this case, the CIDI-SC
or PCL) designed to provide a proxy measure for the
unmeasured variable of interest (in this case, DSM-IV/SCID
diagnoses), but also other variables that might be used
in second-phase analyses as predictors or consequences
of the imputed variable. This is important because the
use of only the CIDI-SC or PCL to impute clinical
diagnoses would lead to under-estimation of the associ-
ations of predictors and consequences of clinical diag-
noses with the components of the clinical diagnoses
that are not predicted by the CIDI-SC or PCL scores
(Collins et al., 2001). As a result, the multiply-imputed
predicted probabilities of DSM-IV/SCID diagnoses in
Army STARRS were based on complex multivariate
equations that included the complete set of CIDI-SC/PCL
scores to impute each clinical diagnosis (to adjust for
comorbidities among clinical disorders) along with a wide
range of substantive correlates included in the AAS and
Army/Department of Defense administrative data systems.
We produced 20 imputations for each respondent in Army
STARRS, a number at the high end of the number
recommended in applying MI (Graham et al., 2007).Results
Concordance of screening scale scores with
DSM-IV/SCID diagnoses
Differences in prevalence estimates based on the dichoto-
mized screening scales and SCID are insigniﬁcant for all
disorders at optimal screening scale thresholds for estimat-
ing prevalence (x21 = 0.0–0.6, p= 0.89–0.43). (Table 1) This
is not surprising, of course, as the thresholds were selected
to make CIDI-SC prevalence as similar as possible to SCID
prevalence. But this is no guarantee of good concordance
at the individual level. Individual-level diagnostic concor-
dance at these thresholds is moderate for seven diagnoses
(AUC= 0.70–0.79) and fair for the other diagnosis
(ADHD; AUC= 0.69). Total classiﬁcation accuracy is
in the range 86.0–95.9%. The screening scale estimate
of 30-day prevalence of any of the seven disorders
assessed for 30-day prevalence (the exception being
MHM, which was only assessed over the entire life-
time), like most of the individual disorders, has moder-
ate concordance with the estimate based on the SCID
(AUC= 0.78).hods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.1002/mpr
Copyright © 2013 John Wiley & Sons, Ltd.
Table 1. Aggregate (McNemar x2) and individual-level (AUC, κ, TCA) consistency of DSM-IV diagnoses based on the CIDI
screening scales (CIDI-SC) at their optimal (to estimate prevalence) thresholds and on blinded SCID clinical reappraisal
interviews (n=460)a
Aggregate concordanceb Individual-level concordancec
Prevalence estimates
CIDI-SC SCID McNemar
Percent (SE) Percent (SE) x21 AUC κ TCA
I. Mood disorders
Major depressive episode 6.8 (1.0) 6.7 (1.0) 0.0 0.78 0.55 94.3
Mania/hypomania 4.9 (1.0) 5.2 (0.9) 0.1 0.70 0.42 94.4
II. Anxiety disorders
Panic disorder 5.0 (0.9) 5.1 (0.7) 0.0 0.78 0.57 95.9
Generalized anxiety disorder 6.6 (0.9) 6.8 (1.0) 0.0 0.70 0.41 92.6
Post-traumatic stress disorder 6.7 (1.0) 6.4 (0.8) 0.1 0.75 0.49 93.7
III. Externalizing disorders
Adult attention-deficit/hyperactivity disorder 8.2 (1.1) 7.1 (1.1) 0.6 0.69 0.35 90.8
Intermittent explosive disorder 20.8 (2.3) 20.4 (2.0) 0.1 0.79 0.57 86.0
Substance use disorder 4.9 (0.4) 5.4 (0.8) 0.1 0.73 0.47 94.8
IV. Any disorderd 18.9 (1.6) 20.3 (1.9) 0.6 0.78 0.58 86.6
aAnalyses are based on weighted data to adjust for the over-sampling of respondents screening positive on the CIDI-SC scales.
bThe CIDI-SC prevalence estimates are set at the thresholds designed to maximize concordance with prevalence estimates
based on the blinded SCID clinical reappraisal interviews. The McNemar x2 tests evaluate concordance of these two preva-
lence estimates.
cAUC=area under the receiver operating characteristic curve; κ=Cohen’s κ; TCA= total classification accuracy. See the text
for definitions of these statistics, all three of which provide information about the overall individual-level concordance between
diagnoses based on the CIDI-SC and the blinded SCID clinical reappraisal interviews.
dAny of the seven disorders other than mania/hypomania, as mania/hypomania were assessed only over the entire lifetime.
Kessler et al. Clinical reappraisal of the CIDI-SC in Army STARRSOperating characteristics of the tests
The proportions of SCID cases detected (SN) at the opti-
mal screening scale diagnostic thresholds for estimating
SCID prevalence are in the range 42.8–66.8% and the pro-
portions of screening scale cases conﬁrmed by the SCID
(PPV) at these thresholds are in the range 37.1–65.3%
(68.3% for any 30-day disorder) (Table 2). The propor-
tions of SCID non-cases classiﬁed correctly (SP) are
90.9–97.9% and the proportions of screening scale non-
cases conﬁrmed as non-cases by the SCID (NPV) are
91.5–97.8%. Lower SN and PPV than SP and NPV are
expected for thresholds designed to estimate prevalence
without bias when only a minority of respondents has a
disorder. LR+ is generally considered more informative
than SN in such cases (Haynes et al., 2006). LR + is in
the deﬁnitive range (i.e. greater than 10.0) at these thresh-
olds for six of the eight disorders and in the informativeInt. J. Methods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.100
Copyright © 2013 John Wiley & Sons, Ltd.range (i.e. greater than 5.0) for the others (7.3 for IED;
7.8 for ADHD) and for any 30-day disorder (8.5), indicat-
ing that screened positives at these thresholds are much
more likely than screened negatives to be conﬁrmed as
cases in the clinical reappraisal interviews. LR values,
in comparison, are in a range that would not be consid-
ered useful in screening out true non-cases (0.4–0.6).The implications of modifying diagnostic thresholds
The proportions of screened positives conﬁrmed as SCID
cases (PPV) could be increased by raising the screening
scale diagnostic thresholds beyond the optimal for esti-
mating prevalence. However, this increase in PPV would
be obtained at the expense of decreasing SN and creating
downwardly biased (conservative) prevalence estimates.
The value of making such a change in threshold while still
attempting to approximate clinical prevalence can be2/mpr
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Table 2. CIDI screening scale (CIDI-SC) operating characteristics at optimal thresholds for estimating DSM-IV/SCID
prevalence (n=460)a
Positive operating characteristicsb Negative operating characteristicsc
SN (SE) PPV (SE) LR+ SP (SE) NPV (SE) LR
I. Mood disorders
Major depressive episode 58.8 (9.0) 57.5 (6.6) 19.0 96.9 (0.8) 97.0 (0.9) 0.4
Mania/hypomania 43.5 (8.9) 45.8 (6.3) 15.5 97.2 (0.6) 96.9 (0.8) 0.6
II. Anxiety disorders
Panic disorder 58.5 (11.2) 59.5 (7.7) 27.9 97.9 (0.4) 97.8 (0.6) 0.4
Generalized anxiety disorder 43.9 (4.7) 45.6 (7.4) 11.5 96.2 (0.8) 95.9 (0.7) 0.6
Post-traumatic stress disorder 53.7 (6.9) 50.8 (7.0) 15.3 96.5 (0.8) 96.8 (0.6) 0.5
III. Externalizing disorders
Adult attention-deficit/hyperactivity disorder 42.8 (7.8) 37.1 (7.0) 7.8 94.5 (1.1) 95.6 (1.0) 0.6
Intermittent explosive disorder 66.8 (6.2) 65.3 (5.2) 7.3 90.9 (1.6) 91.5 (1.6) 0.4
Substance use disorder 47.6 (8.5) 51.6 (8.0) 19.0 97.5 (0.5) 97.0 (0.8) 0.5
IV. Any disorderd 63.7 (4.3) 68.3 (4.0) 8.5 92.5 (1.2) 90.9 (1.6) 0.4
aAnalyses are based on weighted data to adjust for the over-sampling of respondents screening positive on the CIDI-SC
scales.
bSN= sensitivity (the percent of SCID cases detected by the CIDI-SC); PPV= positive predictive value (the percent of
CIDI-SC cases confirmed by the SCID); LR + = likelihood ratio positive (the relative proportions of SCID cases among
CIDI-SC cases versus non-cases).
cSP= specificity (the percent of SCID non-cases classified as non-cases by the CIDI-SC); NPV=negative predictive value
(the percent of CIDI-SC non-cases confirmed as non-cases by the SCID); LR= likelihood ratio negative (the relative
proportions of SCID non-cases among CIDI-SC cases versus non-cases).
dAny of the seven disorders other than mania/hypomania, as mania/hypomania were assessed only over the entire lifetime.
Clinical reappraisal of the CIDI-SC in Army STARRS Kessler et al.evaluated by examining relative changes in PPV versus SN
associated with modest increases in screening scale thresh-
olds around the optimal thresholds for estimating SCID
prevalence. When we make these small increases in
threshold we see that the increases in PPV are much less
than the decreases in SN for four disorders (MDE, GAD,
ADHD, SUD) (proportional screening scales decreases of
20%, 7%, 25%, and 31%, respectively; proportional PPV
increases of 2%, 0%, 18%, and 4%, respectively) (Table 3).
In addition, PPV actually decreases slightly for the other
four disorders due to respondents with CIDI-SC scores
just above the optimal thresholds for estimating SCID
prevalence of these disorders having high SCID preva-
lence. These results argue against small changes to increase
the screening scale thresholds in the service of making
diagnoses more conservative while still maintaining esti-
mates that approximate the SCID prevalence estimates.
We also examined the implications of making small
changes in the thresholds in the other direction to increase
the proportions of clinical cases screening positive by
lowering the screening scale thresholds. Such changes
increase SN by deﬁnition. This is desirable for purposesInt. J. Met
312of guaranteeing comprehensive detection in treatment
samples when PPV does not decrease more than SN
increases. However, such anticonservative changes can
lead to upward bias in prevalence estimates as well as to
reductions in LR+when the proportional increases in
SN are lower than the proportional decreases in SP. An
analysis of these changes associated with modest decreases
in screening scale thresholds shows that LR+ consistently
decreases when modest changes are made to decrease
thresholds (Table 3). These results argue against making
the screening scale thresholds less conservative while still
maintaining estimates that approximate SCID prevalence.Selecting alternative optimization rules in selecting
screening scale diagnostic thresholds
As noted earlier in the section on analysis methods, the most
useful thresholds for screening scales differ depending on
the uses to which the screening scales are put. As Army
STARRS is an epidemiological study rather than a clinical
study, we place a premium on accurate estimation of SCID
prevalence. But in a clinical study, where screening scaleshods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.1002/mpr
Copyright © 2013 John Wiley & Sons, Ltd.
Table 3. Variation in CIDI screening scale (CIDI-SC) operating characteristics when diagnostic thresholds are changed from
the optimal for estimating prevalence to either more conservative or more anticonservative thresholds (n=460)a
CIDI-SC prevalence
estimateb
Positive operating
characteristicsc
Negative operating
characteristicsd
Percent (SE) SN (SE) PPV (SE) LR+ SP (SE) NPV (SE) LR
Major depressive episode
Conservative 6.0 (0.8) 49.1 (8.8) 54.9 (8.5) 16.9 97.1 (0.7) 96.4 (1.0) 0.5
Optimal 6.8 (1.0) 58.8 (9.0) 57.5 (6.6) 19.0 96.9 (0.8) 97.0 (0.9) 0.4
Anticonservative 7.5 (1.2) 62.5 (9.2) 55.6 (6.3) 17.4 96.4 (0.9) 97.3 (0.9) 0.4
Mania/hypomania
Conservative 2.7 (0.5) 20.9 (5.9) 39.5 (8.3) 12.3 98.3 (0.4) 95.8 (1.0) 0.8
Optimal 4.9 (1.0) 43.5 (8.9) 45.8 (6.3) 15.5 97.2 (0.6) 96.9 (0.8) 0.6
Anticonservative 11.6 (1.4) 72.6 (9.1) 32.3 (6.6) 8.7 91.7 (1.4) 98.4 (0.6) 0.3
Panic disorder
Conservative 3.4 (0.7) 37.1 (9.9) 54.8 (8.9) 23.2 98.4 (0.4) 96.7 (0.7) 0.6
Optimal 5.0 (0.9) 58.5 (11.2) 59.5 (7.7) 27.9 97.9 (0.4) 97.8 (0.6) 0.4
Anticonservative 6.4 (0.9) 71.4 (10.4) 57.1 (6.9) 24.6 97.1 (0.5) 98.4 (0.5) 0.3
Generalized anxiety disorder
Conservative 6.0 (0.8) 40.8 (4.6) 46.7 (7.7) 10.9 96.6 (0.8) 95.7 (0.7) 0.5
Optimal 6.6 (0.9) 43.9 (4.7) 45.6 (7.4) 11.5 96.2 (0.8) 95.9 (0.7) 0.6
Anticonservative 7.1 (1.0) 44.2 (4.8) 42.6 (7.8) 10.0 95.6 (1.0) 95.9 (0.7) 0.6
Post-traumatic stress disorder
Conservative 6.2 (1.0) 46.0 (7.0) 47.5 (7.2) 13.1 96.5 (0.9) 96.3 (0.7) 0.6
Optimal 6.7 (1.0) 53.7 (6.9) 50.8 (7.0) 15.3 96.5 (0.8) 96.8 (0.6) 0.5
Anticonservative 7.7 (1.1) 56.8 (7.2) 47.2 (6.3) 13.2 95.7 (0.9) 97.0 (0.6) 0.4
Adult attention-deficit/hyperactivity disorder
Conservative 6.8 (1.1) 31.8 (6.2) 33.4 (6.8) 6.5 95.1 (1.1) 94.8 (1.0) 0.7
Optimal 8.2 (1.1) 42.8 (7.8) 37.1 (7.0) 7.8 94.5 (1.1) 95.6 (1.0) 0.6
Anticonservative 8.8 (1.1) 44.1 (7.9) 35.5 (6.5) 7.2 93.9 (1.1) 95.7 (1.0) 0.5
Intermittent explosive disorder
Conservative 16.8 (1.4) 47.3 (4.5) 57.2 (5.5) 5.2 90.9 (1.6) 87.1 (2.0) 0.6
Optimal 20.8 (2.3) 66.8 (6.2) 65.3 (5.2) 7.3 90.9 (1.6) 91.5 (1.6) 0.4
Anticonservative 26.7 (3.3) 73.5 (7.4) 56.0 (5.7) 5.0 85.3 (2.7) 92.6 (1.9) 0.9
Substance use disorder
Conservative 4.1 (0.5) 38.1 (8.3) 49.5 (8.4) 17.3 97.8 (0.4) 96.5 (0.8) 0.6
Optimal 4.9 (0.4) 47.6 (8.5) 51.6 (8.0) 19.0 97.5 (0.5) 97.0 (0.8) 0.5
Anticonservative 6.7 (0.6) 57.3 (9.1) 45.6 (5.6) 14.7 96.1 (0.5) 97.5 (0.8) 0.4
aAnalyses are based on weighted data to adjust for the over-sampling of respondents screening positive on the CIDI-SC scales.
bThe CIDI-SC prevalence estimates are varied by changing the threshold to values both above (conservative) and below
(anticonservative) the thresholds designed to maximize concordance with prevalence estimates based on the blinded SCID
clinical reappraisal interviews.
cSN= sensitivity (the percent of SCID cases detected by the CIDI-SC); PPV= positive predictive value (the percent of
CIDI-SC cases confirmed by the SCID); LR + = likelihood ratio positive (the relative proportions of SCID cases among
CIDI-SC cases versus non-cases).
dSP= specificity (the percent of SCID non-cases classified as non-cases by the CIDI-SC); NPV=negative predictive value
(the percent of CIDI-SC non-cases confirmed as non-cases by the SCID); LR= likelihood ratio negative (the relative
proportions of SCID non-cases among CIDI-SC cases versus non-cases).
Kessler et al. Clinical reappraisal of the CIDI-SC in Army STARRSmight be used for case-ﬁnding to select people for additional
assessment and treatment, it might make more sense to
lower the threshold to capture as large a proportion ofInt. J. Methods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.100
Copyright © 2013 John Wiley & Sons, Ltd.clinical cases as feasible within the constraints of the cost-
beneﬁt ratio of screening and treatment. To investigate
the implications of using such a rule in setting2/mpr
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Clinical reappraisal of the CIDI-SC in Army STARRS Kessler et al.screening scale thresholds, we compared scale operating
characteristics when the threshold was selected to
detect 80% of DSM-IV/SCID cases (i.e. SN = 80.0%).
This change leads to a lowering of screening scale
thresholds for all disorders because SN is consistently
lower than 80% at the optimal threshold for estimating
SCID prevalence. And this, in turn, leads to substantial
increases in screening scale prevalence (2.5–7.0 times the
prevalence estimates based on the optimal threshold forTable 4. Variation in CIDI screening scale (CIDI-SC) operating c
(i) the optimal for estimating prevalence to (ii) having high SN (i.
CIDI-SC prevalence
estimateb
P
Percent (SE) SN
Major depressive episode
Optimal for prevalence 6.8 (1.0) 58.8
High SN 25.2 (2.1) 80.2 (1
Mania/hypomania
Optimal for prevalence 4.9 (1.0) 43.5
High SN 20.5 (2.2) 82.7
Panic disorder
Optimal for prevalence 5.0 (0.9) 58.5 (1
High SNe 6.4 (0.9) 71.4 (1
Generalized anxiety disorder
Optimal for prevalence 6.6 (0.9) 43.9
High SN 19.1 (2.1) 80.6
Post-traumatic stress disorder
Optimal for prevalence 6.7 (1.0) 53.7
High SN 43.5 (4.0) 81.2
Adult attention-deficit/hyperactivity disorder
Optimal for prevalence 8.2 (1.1) 42.8
High SN 40.3 (2.9) 84.3
Intermittent explosive disorder
Optimal for prevalence 20.8 (2.3) 66.8
High SNe 26.7 (3.3) 73.5
Substance use disorder
Optimal for prevalence 4.9 (0.4) 47.6
High SNe 12.4 (1.6) 66.8
aAnalyses are based on weighted data to adjust for the over-samp
bThe CIDI-SC prevalence estimates are varied by changing th
blinded SCID clinical reappraisal interviews.
cSN=sensitivity (the percent of SCID cases detected by the CIDI
cases confirmed by the SCID); LR+= likelihood ratio positive (th
versus non-cases).
dSP= specificity (the percent of SCID non-cases classified as n
(the percent of CIDI-SC non-cases confirmed as non-cases by
portions of SCID non-cases among CIDI-SC cases versus non-
eAs none of the CIDI-SC thresholds for this disorder had SN as
Int. J. Met
314estimating SCID prevalence) for all disorders other than
PD and IED (where CIDI-SC prevalence estimates
increase to 1.2–1.3 times the optimal for estimating SCID
prevalence) and to correspondingly large reductions in
PPV (Table 4). While PPV at the optimal threshold for
estimating SCID prevalence averages 51.6% (i.e. 51.6%
of screened positives are true clinical cases, with a range
37.1–65.3%), average PPV drops to 30.0% (range: 11.9–57.1%)
when thresholds are selected so that SN exceed 80%. Thisharacteristics when diagnostic thresholds are changed from
e. detecting at least 80% of DSM-IV/SCID cases) (n= 460)a
ositive operating
characteristicsc
Negative operating
characteristicsd
(SE) PPV (SE) LR+ SP (SE) NPV (SE) LR
(9.0) 57.5 (6.6) 19.0 96.9 (0.8) 97.0 (0.9) 0.4
1.8) 21.3 (3.1) 3.8 78.7 (2.1) 98.2 (1.2) 0.3
(8.9) 45.8 (6.3) 15.5 97.2 (0.6) 96.9 (0.8) 0.6
(8.4) 20.8 (4.1) 4.8 82.9 (2.1) 98.9 (0.6) 0.2
1.2) 59.5 (7.7) 27.9 97.9 (0.4) 97.8 (0.6) 0.4
0.4) 57.1 (6.9) 24.6 97.1 (0.5) 98.4 (0.5) 0.3
(4.7) 45.6 (7.4) 11.5 96.2 (0.8) 95.9 (0.7) 0.6
(5.2) 28.9 (5.3) 5.5 85.4 (2.3) 98.4 (0.5) 0.2
(6.9) 50.8 (7.0) 15.3 96.5 (0.8) 96.8 (0.6) 0.5
(6.6) 11.9 (2.0) 2.0 59.0 (4.2) 97.9 (0.8) 0.3
(7.8) 37.1 (7.0) 7.8 94.5 (1.1) 95.6 (1.0) 0.6
(7.5) 14.9 (2.5) 2.3 63.1 (3.1) 98.1 (1.0) 0.2
(6.2) 65.3 (5.2) 7.3 90.9 (1.6) 91.5 (1.6) 0.4
(7.4) 56.0 (5.7) 5.0 85.3 (2.7) 92.6 (1.9) 0.3
(8.5) 51.6 (8.0) 19.0 97.5 (0.5) 97.0 (0.8) 0.5
(9.,4) 28.8 (5.4) 7.1 90.6 (1.7) 98.0 (0.8) 0.4
ling of respondents screening positive on the CIDI-SC scales.
e threshold to have a minimum SN of 80.0% based on the
-SC); PPV=positive predictive value (the percent of CIDI-SC
e relative proportions of SCID cases among CIDI-SC cases
on-cases by the CIDI-SC); NPV=negative predictive value
the SCID); LR= likelihood ratio negative (the relative pro-
cases).
high as 80%, the threshold with the highest SN is reported.
hods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.1002/mpr
Copyright © 2013 John Wiley & Sons, Ltd.
Kessler et al. Clinical reappraisal of the CIDI-SC in Army STARRSmeans that it would require an average of about three
SCID interviews to detect each clinical case among the
screened positives at the lower threshold compared to
roughly two at the higher threshold. Clinical intervention
cost-effectiveness calculations would be needed to deter-
mine whether this additional expense of case-ﬁnding
could be justiﬁed based on the human costs (i.e. quality
of life, morbidity, mortality) of an untreated case, the
costs of treatment, and the likely effectiveness of treat-
ment in reducing human costs. From the perspective of
epidemiological research, lowering the thresholds below
the optimal for estimating prevalence might still be desir-
able even though such an anticonservative change
introduces upward bias in prevalence estimates, as it is
possible that lowering thresholds will lead to greater
proportional increases in SN than in (100 SP), in which
case LR +will increase. However, LR + decreases consis-
tently when the screening scale thresholds are lowered,
arguing against making these thresholds less conservative
for purposes of epidemiological analysis of the Army
STARRS data.
Another goal of screening might be to select screening
scale thresholds to have a minimum proportion of screened
positives conﬁrmed in clinical interviews (i.e. high PPV).
For example, minimum PPVmight be set at 50% to guaran-
tee that the majority of screened positives are true clinical
cases or at 80% to guarantee that the vast majority of
screened positives are true clinical cases. However, this will
lead to a reduction in SN that might make the true cases
detected unrepresentative of all true cases. If minimum
PPV is set at 50%, the thresholds selected to maximize esti-
mation of SCID prevalence meet the PPV criterion in ﬁve of
eight cases, the exceptions being MHM (PPV=45.8%),
GAD (PPV=45.6%), and ADHD (PPV=37.1%). In the
case of MHM, the threshold can be raised to increase PPV
to 71.1%, but this leads to a dramatic reduction in estimated
prevalence (from 4.9% to 0.7%) and in SN (from 43.5% to
9.7%) (Table 5). While more than two-thirds of the small
fraction of respondents deﬁned as positive for MHM in
the CIDI-SC are SCID cases, the exclusion of the vast
majority of SCID cases of MHM from this small fraction
(100 SN=90.3% of SCID cases not detected) means that
the proportion of SCID cases among the screened negatives
is nearly as high as the proportion among screened negatives
(LR= 0.9), arguing against making the screening scale
thresholds this conservative for purposes of epidemiological
analysis of the Army STARRS data.
In the case of GAD, raising the CIDI-SC threshold to
make PPV exceed 50% leads to halving both estimated
prevalence (from 6.6% to 3.2%) and SN (from 43.9% to
23.6%) in the service of only a relatively modest increaseInt. J. Methods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.100
Copyright © 2013 John Wiley & Sons, Ltd.in PPV (from 45.6% to 50.2%) compared to when the
threshold is set to maximize estimation of SCID preva-
lence. It is difﬁcult to argue for a threshold that decreases
SN so dramatically for such a modest increase in PPV. The
situation is similar but less dramatic for ADHD, where a
change in the CIDI-SC threshold that increased PPV by
roughly 50% (from 37.1% to 55.9%) decreased estimated
prevalence by 70% (from 8.2% to 2.4%) and SN by 55%
(from 42.8% to 19.3%). Selecting thresholds to have even
higher PPV (a minimum of 80%) for disorders where
screening scale PPV is greater than 50% at the optimal
threshold for estimating SCID prevalence consistently
has the same negative effects in that the proportional
increases in PPV (in the range 47–59%) are much less
than the proportional decreases in prevalence (84–91%),
resulting in extremely low levels of SN (7.3–13.4%). These
results argue against using such restrictive thresholds
for purposes of epidemiological analysis of the Army
STARRS data.Continuous versus dichotomous
diagnostic classification
As noted earlier in the section on analysis methods, we
calculated ROC curves for the entire screening scale distri-
butions (Figure 1). AUC was calculated for each of these
curves and compared to the AUC of the dichotomous
version of the same screening scale. AUC was found to
be substantially higher for the continuous than dichoto-
mous scoring rule for each of the eight screening scales
(Range: 0.80–0.90 continuous versus 0.69–0.79 dichoto-
mous; inter-quartile range: 0.85–0.87 continuous versus
0.70–0.78 dichotomous) (Table 6). This suggests that
meaningful variation in SCID prevalence exists at other
places on the screening scale ranges than the optimal diag-
nostic threshold for estimating SCID prevalence. The
important implication of this ﬁnding for our purposes is
that continuous screening scale scores deﬁning predicted
probabilities of clinical diagnoses might be more useful
than dichotomous diagnostic classiﬁcations based on the
screening scales for purposes of epidemiological analysis.
We consequently calculated both continuous (predicted
probability of having a DSM-IV/SCID diagnosis) and
dichotomous versions of each screening scale for use in
analysis of the Army STARRS data. The continuous
versions were produced using the MI method. Impor-
tantly, not only the screening scale scores but also a wide
range of other signiﬁcant correlates of the DSM-IV/SCID
diagnoses were used in the ﬁrst-phase MI analysis in order
to minimize bias in subsequent substantive analyses that2/mpr
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Table 5. Variation in CIDI screening scale (CIDI-SC) operating characteristics when diagnostic thresholds are changed from
(i) the optimal for estimating prevalence to (ii) having high PPV (i.e. at least 80% of screened positives having a DSM-IV/SCID
diagnosis) (n=460)a
CIDI-SC prevalence
estimateb
Positive operating
characteristicsc
Negative operating
characteristicsd
Percent (SE) SN (SE) PPV (SE) LR+ SP (SE) NPV (SE) LR–
Major depressive episode
Optimal for prevalence 6.8 (1.0) 58.8 (9.0) 57.5 (6.6) 19.0 96.9 (0.8) 97.0 (0.9) 0.4
High PPV 0.6 (0.3) 7.3 (4.1) 84.7 (11.5) 73.0 99.9 (0.1) 93.8 (1.0) 0.9
Mania/hypomania
Optimal for prevalence 4.9 (1.0) 43.5 (8.9) 45.8 (6.3) 15.5 97.2 (0.6) 96.9 (0.8) 0.6
High PPVe 0.7 (0.2) 9.7 (3.0) 71.1 (12.5) 48.5 99.8 (0.1) 95.3 (1.0) 0.9
Generalized anxiety disorder
Optimal for prevalence 6.6 (0.9) 43.9 (4.7) 45.6 (7.4) 11.5 96.2 (0.8) 95.9 (0.7) 0.6
PPV GT 50% 3.2 (0.6) 23.6 (3.9) 50.2 (8.5) 13.9 98.3 (0.5) 94.6 (0.9) 0.8
High PPVe 1.0 (0.3) 10.4 (3.5) 69.1 (12.2) 34.7 99.7 (0.2) 93.8 (0.9) 0.9
Post-traumatic stress disorder
Optimal for prevalence 6.7 (1.0) 53.7 (6.9) 50.8 (7.0) 15.3 96.5 (0.8) 96.8 (0.6) 0.5
High PPVe 1.1 (0.3) 13.4 (3.3) 79.5 (10.5) 67.0 79.5 (10.5) 99.8 (0.1) 0.9
Adult attention-deficit/hyperactivity disorder
Optimal for prevalence 8.2 (1.1) 42.8 (7.8) 37.1 (7.0) 7.8 94.5 (1.1) 95.6 (1.0) 0.6
PPV GT 50% 2.4 (0.5) 19.3 (3.8) 55.9 (12.0) 16.1 98.8 (0.4) 94.1 (1.0) 0.8
High PPVe 2.0 (0.4) 17.8 (3.7) 63.1 (12.7) 22.3 99.2 (0.3) 94.1 (0.9) 0.8
Substance use disorder
Optimal for prevalence 4.9 (0.4) 47.6 (8.5) 51.6 (8.0) 19.0 97.5 (0.5) 97.0 (0.8) 0.5
High PPV 0.6 (0.2) 8.8 (3.6) 81.7 (13.3) 88.0 99.9 (0.1) 95.1 (0.8) 0.9
aAnalyses are based on weighted data to adjust for the over-sampling of respondents screening positive on the CIDI-SC scales.
bThe CIDI-SC prevalence estimates are varied by changing the threshold to have a minimum PPV of 80.0% based on the
blinded SCID clinical reappraisal interviews. Results are not reported for PD or IED because optimal thresholds for predicting
SCID prevalence of these disorders also had the highest values of PPV.
cSN=sensitivity (the percent of SCID cases detected by the CIDI-SC); PPV=positive predictive value (the percent of CIDI-SC
cases confirmed by the SCID); LR+= likelihood ratio positive (the relative proportions of SCID cases among CIDI-SC cases ver-
sus non-cases).
dSP= specificity (the percent of SCID non-cases classified as non-cases by the CIDI-SC); NPV=negative predictive value
(the percent of CIDI-SC non-cases confirmed as non-cases by the SCID); LR= likelihood ratio negative (the relative pro-
portions of SCID non-cases among CIDI-SC cases versus non-cases).
eAs none of the CIDI-SC thresholds for this disorder had PPV as high as 80%, the threshold with the highest PPV is reported.
Clinical reappraisal of the CIDI-SC in Army STARRS Kessler et al.will use these variables as correlates of predicted probabili-
ties of DSM-IV/SCID disorders.Discussion
Previous research has shown that CIDI-SC operating
characteristics are equivalent to or better than those of
alternative screening scales in samples of the general
population (Kessler et al., 2005a; Kessler et al., 2006a;
Kessler et al., 2013a) and that the PCL has very good
concordance with clinical diagnoses of PTSD in samples
of both the military and the general population (WilkinsInt. J. Met
316et al., 2011). We nonetheless carried out an independent
CRS of these screening scales in Army STARRS due to the fact
that the operating characteristics of the same screening scale
can differ substantially across surveys depending on such fun-
damental survey conditions as auspices, level of conﬁdential-
ity (e.g. complete anonymity versus de-identiﬁcation), mode
of data collection, and situational factors, such as constraint
on the amount of time available to complete the survey
(Kessler and Pennell, in press).
It is not surprising in light of the challenging survey con-
ditions in Army STARRS – including group-administration
in settings with suboptimal physical facilities (e.g. sitting onhods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.1002/mpr
Copyright © 2013 John Wiley & Sons, Ltd.
Figure 1. ROC curves for the associations between continu-
ous screening scales and DSM-IV/SCID diagnoses (n=460).
ROC= receiver operating characteristic; SN=sensitivity;
SP=specificity; DSM-IV=Diagnostic and Statistical Manuel
of Mental Disorders, Fourth Edition; SCID=Structured
Clinical Interview for DSM-IV.
Table 6. Comparison of area under the receiver operating
characteristic curve (AUC) based on the dichotomous
versions of the CIDI-SC scales as the optimal thresholds for
estimating DSM-IV/SCID prevalence and based on the
continuous versions of the CIDI-SC scales (n= 460)a
Area under the curve
(AUC)
Dichotomous Continuous
I. Mood disorders
Major depressive episode 0.78 0.90
Mania/hypomania 0.70 0.86
II. Anxiety disorders
Panic disorder 0.78 0.90
Generalized anxiety disorder 0.70 0.87
Post-traumatic stress disorder 0.75 0.81
III. Externalizing disorders
Adult attention deficit/
hyperactivity disorder
0.69 0.85
Intermittent explosive disorder 0.79 0.86
Substance use disorder 0.73 0.80
aAnalyses are based on weighted data to adjust for the
over-sampling of respondents screening positive on the
CIDI-SC scales.
Kessler et al. Clinical reappraisal of the CIDI-SC in Army STARRSfolding chairs in full ﬁeld gear in temporary data collection
locations) – that we found that the CIDI-SC and PCL AUCs
are somewhat lower than in previous psychometric studies
of these scales. Individual-level concordance of diagnosesInt. J. Methods Psychiatr. Res. 22(4): 303–321 (2013). DOI: 10.100
Copyright © 2013 John Wiley & Sons, Ltd.based on the CIDI-SC and PCL with diagnoses based on
independent SCID clinical reappraisal interviews in the AAS
is for most part moderate (AUC=0.70–0.79; κ=0.4–0.6),
whereas most previous evaluations found concordance of
the CIDI-SC and the PCL with SCID diagnoses to be
substantial (AUC=0.80–0.89; κ=0.6–0.8). However, the
administrative conditions of the screening scales in most pre-
vious studies that carried out clinical reappraisals were much
better than in Army STARRS, including self-administration in
primary care waiting rooms (Kessler et al., 2013a), face-to-
face interviewer administration in household surveys (Kessler
et al., 2006a), and interviewer administration over the
telephone with health plan subscribers (Kessler et al., 2005a).
Perhaps the more striking result in light of the chal-
lenging Army STARRS ﬁeld conditions is that the positive
CIDI-SC/PCL operating characteristics for dichotomous
versions of the scales designed to optimize aggregate con-
cordance with SCID prevalence estimates are generally
quite good. LR+ values for six of the eight disorders are
in the range 11.5–27.9, all of which are well above the
10.0 value generally considered sufﬁcient to rule in diag-
noses (Haynes et al., 2006), while the 7.3–7.8 LR+ values
for the other two diagnoses and the 8.5 LR+ value for any
30-day disorder are well above the 5.0 value considered
useful in ruling in diagnoses. However, these good LR+
values are accompanied by LR values generally considered
not to be useful in screening out true negatives (0.4–0.6);
that is, to contain proportions of true negative that are not
strikingly different from the proportions found among
screened positives.
As discussed in more detail elsewhere (Kessler et al.,
2013a), the deﬁnitions of screened positives and screened
negatives could be puriﬁed for clinical purposes by
selecting thresholds at the tails of the distributions that
have operating characteristics deemed useful for clinical
purposes. For example, an upper threshold of a screening
scale could be selected to have a minimum PPV of 0.5 in
order to make sure that at least 50% of screened positives
are SCID cases. As we saw, though, this desirable feature of
that threshold would generally mean that a substantial
proportion of SCID cases are missed. Alternatively, the
upper threshold of a screening scale could be set at a
minimum SN of 0.80 to make sure that the vast majority
of SCID cases are picked up by the screen, but this
desirable feature of that threshold would mean that only
a small proportion of screened positives have SCID diag-
noses. In a similar way, a lower threshold of a screening
could be puriﬁed by requiring NPV to be, say, at least 1
– p/5, where p= SCID prevalence of the disorder, thereby
guaranteeing that the proportion of SCID cases among
patients screening negative is no more than 20% as high2/mpr
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Clinical reappraisal of the CIDI-SC in Army STARRS Kessler et al.as the prevalence of the disorder in the sample, but this
desirable feature of that threshold might mean that a
substantial proportion of true non-cases are excluded
from this ruled-out group.
It is also possible to select multiple thresholds at upper
and lower tails both to maximize the positives (i.e. deﬁni-
tive screen-ins and/or screen-outs) and minimize the
negatives (i.e. minimizing the numbers of false positives
and/or false negatives) and leave one or more intermediate
strata that deﬁne those with high-but-not-deﬁnitively-
high scores, low-but-not-deﬁnitively-low scores, and
uninformative intermediate scores. We noted earlier that
such polychotomous scoring rules are fairly common in
screening scales developed for clnical practice (Guyatt
and Rennie, 2001). Indeed, CIDI-SC polychotomous
thresholds have been developed for exactly this reason to
facilitate the use of these scales in primary care screening
(Kessler et al., 2013a).
However, a more useful approach for purposes of
epidemiological analysis of the screening scales considered
here is likely to be retention of the entire screening scale
range given that AUCs of continuous versions of the
screening scales are higher than AUCs of dichotomized
versions of the scales at their unbiased thresholds. Based
on this observation, we are using MI to assign predicted
probabilities of DSM-IV/SCID diagnoses to all Army
STARRS respondents who completed the screening scales.
We are addressing the uncertainty of inference from pre-
diction equations using imputed rather than observed
values by estimating 20 MI estimates of the predicted
probability of having each clinical diagnosis for each
respondent. The practical use of this approach is illustrated
in a more detailed methodological exposition published
previously in this journal (Kessler and Üstün, 2004) as well
as in a number of subsequent substantive reports that used
this approach to estimate the prevalence and correlates of
several different DSM-IV/SCID disorders in other psychiat-
ric epidemiological studies (Fayyad et al., 2007; Huang et al.,
2009; Kessler et al., 2005a). However, second-phase of MI
analysis can be computationally intensive even after the
ﬁrst-phase multiple imputations, as each model has to be
estimated 20 separate times rather than once and the coefﬁ-
cients in these 20 replicates then need to be combined to
calculate adjusted standard errors. As a result, we also plan
to work with dichotomously-scored screening scale mea-
sures at the optimal diagnostic thresholds and to investigate
the extent to which substantive results differ depending on
whether this dichotomous approach is used instead of MI.
Dichotomous screening scale scoring will be used in cases
where results are relatively insensitive to the more reﬁned
estimates using MI.Int. J. Met
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